Suven Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Last Friday at 10:00 AM
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Full time employees||1193|
|Mailing address||# 8-2-334, SDE Serene Chambers 3rd Floor Road No. 5, Avenue - 7 Banjara Hills Hyderabad 500034 India|
|Phone / Fax||91 40 2354 9414 / 91 40 2354 1152|
Suven Pharmaceuticals Limited paid ₹0.00 dividend and the ex-dividend date was 09 Sept 2022.The dividend payout ratio is 17.70%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SUVENPHAR dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
SUVENPHAR's forward dividend amount is ₹3 and the forward dividend yield is 0.65%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Dec 2022, following are the company executives and directors listed on Suven Pharmaceuticals Limited.
|Mr. Venkateswarlu Jasti M.Pharm. M.S.||MD & Exec. Director||72||98.16M|
|Mr. Subba Rao Parupalli C.M.A.||Chief Financial Officer|
|Mr. K. Hanumantha Rao||Company Sec. & Compliance Officer||58|
|Mr. Sunder Venkatraman||VP of Corp. Affairs|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Suven Pharmaceuticals Limited is and its enterprise value is .
The SUVENPHAR's stocks Beta value is 2.06 making it 106% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Frequently Asked Questions
1. What is Suven Pharmaceuticals Limited's Stock Symbol?
Suven Pharmaceuticals Limited trades on NSE under the ticker symbol "SUVENPHAR".
2. What is Suven Pharmaceuticals Limited's stock price today?
One share of SUVENPHAR stock can currently be purchased for approximately ₹466.
3. How can I contact Suven Pharmaceuticals Limited?
Suven Pharmaceuticals Limited's mailing address is # 8-2-334, SDE Serene Chambers 3rd Floor Road No. 5, Avenue - 7 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 2354 9414.
4. What is Suven Pharmaceuticals Limited's official website?
The official website of Suven Pharmaceuticals Limited is https://www.suvenpharm.com.